Lipsky, P. E., Calabrese, L. H., Kavanaugh, A., Sundy, J. S., Wright, D., Wolfson, M., & Becker, M. A. (2014). Pegloticase immunogenicity: The relationship between efficacy and antibody development in patients treated for refractory chronic gout. BioMed Central.
Chicago Style CitationLipsky, Peter E., Leonard H. Calabrese, Arthur Kavanaugh, John S. Sundy, David Wright, Marsha Wolfson, and Michael A. Becker. Pegloticase Immunogenicity: The Relationship between Efficacy and Antibody Development in Patients Treated for Refractory Chronic Gout. BioMed Central, 2014.
MLA CitationLipsky, Peter E., et al. Pegloticase Immunogenicity: The Relationship between Efficacy and Antibody Development in Patients Treated for Refractory Chronic Gout. BioMed Central, 2014.